Retatrutide for Weight Loss: Can It Help You Get Shredded?
News Context
At a glance
- Retatrutide, an experimental weight loss drug targeting three hormone pathways involved in appetite, metabolism, and blood sugar regulation, has shown potential for significant weight reduction in early clinical...
- In a 2023 clinical trial, participants receiving higher doses of retatrutide lost more than 20% of their body weight over 48 weeks, with some losing up to a...
- The drug’s mechanism involves activating glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, which together reduce food intake, slow gastric emptying, and increase energy expenditure, leading...
Retatrutide, an experimental weight loss drug targeting three hormone pathways involved in appetite, metabolism, and blood sugar regulation, has shown potential for significant weight reduction in early clinical trials, but remains unapproved for use anywhere in the world and is circulating through illicit online markets.
In a 2023 clinical trial, participants receiving higher doses of retatrutide lost more than 20% of their body weight over 48 weeks, with some losing up to a quarter of their body weight in under a year—nearly twice the effectiveness observed with semaglutide-based drugs like Ozempic and Wegovy.